Kanis, John A.
Norton, Nicholas
Harvey, Nicholas C.
Jacobson, Trolle
Johansson, Helena
Lorentzon, Mattias
McCloskey, Eugene V.
Willers, Carl
Borgström, Fredrik
Article History
Received: 25 November 2020
Accepted: 18 December 2020
First Online: 2 June 2021
Declarations
:
: F Borgström is employed and is a shareholder in Quantify Research, a health economic research consultancy that received a grant from IOF to conduct the analysis. N Norton, C Willers and T Jacobson are employed by Quantify Research, a health economic research consultancy that received a grant from IOF to conduct the analysis. N. Harvey has received consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Kyowa Kirin, Consilient Healthcare, Radius Health and Internis Pharma. EV McCloskey has received consultancy/lecture fees/grant funding/honoraria from AgNovos, Amgen, AstraZeneca, Consilient Healthcare, Fresenius Kabi, Gilead, GSK, Hologic, Internis, Lilly, Merck, Novartis, Pfizer, Radius Health, Redx Oncology, Roche, SanofiAventis, Servier, Synexus, UCB, Viiv, Warner Chilcott, I3 Innovus and Unilever. JA Kanis is the architect of FRAX® but has no financial interest. M Lorentzon has received lecture fees from Amgen, Lilly, Meda, Renapharma, UCB Pharma, and consulting fees from Amgen, Radius Health, UCB Pharma, Renapharma and Consilient Health, all outside the presented work<b>.</b>